Open Access Email this article to a friend

SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?

Maria Tengström*, Arto Mannermaa, Veli-Matti Kosma, Ari Hirvonen and Vesa Kataja

BMC Cancer 2012, 12:257  doi:10.1186/1471-2407-12-257

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?